CD44 and breast carcinoma: In recent decades, BCSCs with the metabolic marker aldehyde dehydrogenases (ALDH) and marker CD44, a small subpopulation of breast cancer cells, have been found to display stem cell capacities, such as self-renewal, long-term repopulation and differentiation [18].